Parathyromatosis: A rare yet problematic etiology of recurrent and persistent hyperparathyroidism

Metabolism: Clinical and Experimental

Volumn 61, Issue 6, 2012, Pages 762-775

  Hage, Mirella P ^a   Salti, Ibrahim ^a   El Hajj Fuleihan, Ghada ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIMIMETIC AGENT; CALCIUM; CINACALCET; FUROSEMIDE; PARATHYROID HORMONE; PHOSPHATE; RALOXIFENE;

ADULT; ARTERIOGRAPHY; BONE DENSITY; CALCIUM BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HYPERPARATHYROIDISM; INTRAOPERATIVE PERIOD; KIDNEY FAILURE; PARATHYROID ADENOMA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROMATOSIS; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; THYMECTOMY; THYROID DISEASE; ULTRASOUND;

HUMANS; HYPERPARATHYROIDISM; PARATHYROID GLANDS; PARATHYROIDECTOMY; RECURRENCE;

EID: 84861574829     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.11.001     Document Type: Review

References (63)

1. J.P. Bilezikian, R. Marcus, and M.A. Levine The parathyroids: basic and clinical concepts 2nd edn 2001 Academic Press San Diego, Calif; London
2. S.A. Wells Jr., M.K. Debenedetti, and G.M. Doherty Recurrent or persistent hyperparathyroidism J Bone Miner Res 17 Suppl 2 2002 N158 N162
3. J.A. Sosa, N.R. Powe, and M.A. Levine Profile of a clinical practice: thresholds for surgery and surgical outcomes for patients with primary hyperparathyroidism: a national survey of endocrine surgeons J Clin Endocrinol Metab 83 1998 2658 2665
4. H.A. Bruining, J.C. Birkenhager, and G.L. Ong Causes of failure in operations for hyperparathyroidism Surgery 101 1987 562 565
5. C. Mariette, L. Pellissier, and F. Combemale Reoperation for persistent or recurrent primary hyperparathyroidism Langenbecks Arch Surg 383 1998 174 179
6. J. Mitchell, M. Milas, and G. Barbosa Avoidable reoperations for thyroid and parathyroid surgery: effect of hospital volume Surgery 144 2008 899 906 [discussion -7]
7. H. Chen, T.S. Wang, and T.W. Yen Operative failures after parathyroidectomy for hyperparathyroidism: the influence of surgical volume Ann Surg 252 2010 691 695
8. W. Shen, M. Duren, and E. Morita Reoperation for persistent or recurrent primary hyperparathyroidism Arch Surg 131 1996 861 867 [discussion 7-9]
9. A.C. Powell, H.R. Alexander, and R. Chang Reoperation for parathyroid adenoma: a contemporary experience Surgery 146 2009 1144 1155
10. G. Akerstrom, J. Malmaeus, and R. Bergstrom Surgical anatomy of human parathyroid glands Surgery 95 1984 14 21
11. R.V. Lloyd SpringerLink (Online service). Endocrine pathology differential diagnosis and molecular advances 2010 Springer Science+Business Media, LLC New York, NY Available from http://dx.doi.org/10.1007/978-1-4419- 1069-1
12. J.P. Bilezikian, R. Marcus, and M.A. Levine The parathyroids 2nd edn 2001 Academic Press San Diego
13. J.M. Ruda, C.S. Hollenbeak, and B.C. Stack Jr A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003 Otolaryngol Head Neck Surg 132 2005 359 372
14. D.S. O'Riordain, T. O'Brien, and C.S. Grant Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2 Surgery 114 1993 1031 1037 [discussion 7-9]
15. P. Hellman, B. Skogseid, and K. Oberg Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1 Surgery 124 1998 993 999
16. E. Shane, and J.P. Bilezikian Parathyroid carcinoma: a review of 62 patients Endocr Rev 3 1982 218 226
17. A. Schantz, and B. Castleman Parathyroid carcinoma. A study of 70 cases Cancer 31 1973 600 605
18. C.A. Wang, and R.D. Gaz Natural history of parathyroid carcinoma. Diagnosis, treatment, and results Am J Surg 149 1985 522 527
19. K. Cohn, M. Silverman, and J. Corrado Parathyroid carcinoma: the Lahey Clinic experience Surgery 98 1985 1095 1100
20. K. Sandelin, N.W. Thompson, and L. Bondeson Metastatic parathyroid carcinoma: dilemmas in management Surgery 110 1991 978 986 [discussion 86-8]
21. A.G. Hakaim, and C.B. Esselstyn Jr Parathyroid carcinoma: 50-year experience at The Cleveland Clinic Foundation Cleve Clin J Med 60 1993 331 335
22. N. Talat, and K.M. Schulte Clinical presentation, staging and long-term evolution of parathyroid cancer Ann Surg Oncol 17 2010 2156 2174
23. R.P. Owen, C.E. Silver, and P.K. Pellitteri Parathyroid carcinoma: a review Head Neck 33 2011 429 436
24. T.W. Yen, T.S. Wang, and K.M. Doffek Reoperative parathyroidectomy: an algorithm for imaging and monitoring of intraoperative parathyroid hormone levels that results in a successful focused approach Surgery 144 2008 611 619 [discussion 9-21]
25. B.C. Padberg, S. Schroder, and W. Jochum Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland Am J Pathol 147 1995 1600 1607
26. J.A. Palmer, W.A. Brown, and W.H. Kerr The surgical aspects of hyperparathyroidism Arch Surg 110 1975 1004 1007
27. R.L. Reddick, J.C. Costa, and S.J. Marx Parathyroid hyperplasia and parathyromatosis Lancet 1 1977 549
28. P.C. Lee, R.B. Mateo, and M.R. Clarke Parathyromatosis: a cause for recurrent hyperparathyroidism Endocr Pract 7 2001 189 192
29. G. Akerstrom, C. Rudberg, and L. Grimelius Recurrent hyperparathyroidism due to peroperative seeding of neoplastic or hyperplastic parathyroid tissue. Case report Acta Chir Scand 154 1988 549 552
30. S. Matsuoka, Y. Tominaga, and T. Sato Recurrent renal hyperparathyroidism caused by parathyromatosis World J Surg 31 2007 299 305
31. A.L. Melck, S.E. Carty, and R.R. Seethala Recurrent hyperparathyroidism and forearm parathyromatosis after total parathyroidectomy Surgery. 148 2010 867 873 [discussion 73-5]
32. P.L. Selby, and M. Peacock Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women N Engl J Med 314 1986 1481 1485
33. R. Marcus, P. Madvig, and M. Crim Conjugated estrogens in the treatment of postmenopausal women with hyperparathyroidism Ann Intern Med 100 1984 633 640
34. A.B. Grey, J.P. Stapleton, and M.C. Evans Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial Ann Intern Med 125 1996 360 368
35. M.R. Rubin, K.H. Lee, and D.J. McMahon Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism J Clin Endocrinol Metab 88 2003 1174 1178
36. J.R. Zanchetta, and C.E. Bogado Raloxifene reverses bone loss in postmenopausal women with mild asymptomatic primary hyperparathyroidism J Bone Miner Res 16 2001 189 190
37. E. Shane, D.C. Baquiran, and J.P. Bilezikian Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism Ann Intern Med 95 1981 23 27
38. N.A. Hamdy, R.E. Gray, and E. McCloskey Clodronate in the medical management of hyperparathyroidism Bone 8 Suppl 1 1987 S69 S77
39. S. Adami, M. Mian, and F. Bertoldo Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment Clin Endocrinol (Oxf) 33 1990 391 397
40. R.S. Schmidli, I. Wilson, and E.A. Espiner Aminopropylidine diphosphonate (APD) in mild primary hyperparathyroidism: effect on clinical status Clin Endocrinol (Oxf) 32 1990 293 300
41. C.A. Reasner, M.D. Stone, and D.J. Hosking Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with risedronate J Clin Endocrinol Metab 77 1993 1067 1071
42. M. Rossini, D. Gatti, and G. Isaia Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism J Bone Miner Res 16 2001 113 119
43. C.C. Chow, W.B. Chan, and J.K. Li Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism J Clin Endocrinol Metab 88 2003 581 587
44. A.A. Khan, J.P. Bilezikian, and A.W. Kung Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial J Clin Endocrinol Metab 89 2004 3319 3325
45. C.R. Parker, P.J. Blackwell, and K.J. Fairbairn Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study J Clin Endocrinol Metab 87 2002 4482 4489
46. P.D. Miller The kidney and bisphosphonates Bone 49 2011 77 81
47. S.J. Silverberg, H.G. Bone III, and T.B. Marriott Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism N Engl J Med 337 1997 1506 1510
48. E. Daphnis, K. Stylianou, and I. Katsipi Parathyromatosis and the challenge of treatment Am J Kidney Dis 48 2006 502 505
49. R. Unbehaun, and W. Lauerwald Successful use of cinacalcet HCl in a patient with end-stage renal failure and refractory secondary hyperparathyroidism due to parathyromatosis Clin Nephrol 67 2007 188 192
50. R. Eriguchi, J. Umakoshi, and Y. Tominaga Successful treatment of inoperable recurrent secondary hyperparathyroidism with cinacalcet HCl NDT Plus 1 2008 218 220
51. M.E. Tublin, J.H. Yim, and S.E. Carty Recurrent hyperparathyroidism secondary to parathyromatosis: clinical and imaging findings J Ultrasound Med 26 2007 847 851
52. E. Hindie, P. Zanotti-Fregonara, and P.A. Just Parathyroid scintigraphy findings in chronic kidney disease patients with recurrent hyperparathyroidism Eur J Nucl Med Mol Imaging 37 2010 623 634
53. D.W. Rattner, G.C. Marrone, and E. Kasdon Recurrent hyperparathyroidism due to implantation of parathyroid tissue Am J Surg. 149 1985 745 748
54. R. Fitko, S.I. Roth, and J.R. Hines Parathyromatosis in hyperparathyroidism Hum Pathol. 21 1990 234 237
55. A. Penington, B Ihle, and V. Billson Recurrent secondary hyperparathyroidism due to implanted parathyroid tissue: a case report Aust N Z J Surg. 60 1990 821 823
56. M. Kessler, J.M. Avila, and E. Renoult Reoperation for secondary hyperparathyroidism in chronic renal failure Nephrol Dial Transplant. 6 1991 176 179
57. M.S. Sokol, J. Kavolius, and M. Schaaf Recurrent hyperparathyroidism from benign neoplastic seeding: a review with recommendations for management Surgery 113 1993 456 461
58. C.F. Kollmorgen, M.R. Aust, and J.A. Ferreiro Parathyromatosis: a rare yet important cause of persistent or recurrent hyperparathyroidism Surgery 116 1994 111 115
59. Z.W. Baloch, D. Fraker, and V.A. LiVolsi Parathyromatosis as cause of recurrent secondary hyperparathyroidism: a cytologic diagnosis Diagn Cytopathol. 25 2001 403 405
60. E.J. Lentsch, K.P. Withrow, and D. Ackermann Parathyromatosis and recurrent hyperparathyroidism Arch Otolaryngol Head Neck Surg. 129 2003 894 896
61. C.F. Evans, L. Mansfield, and A.K. Sharma Recurrent hyperparathyroidism caused by parathyromatosis Hosp Med. 66 2005 424 425
62. C. Stehman-Breen, N. Muirhead, and D. Thorning Secondary hyperparathyroidism complicated by parathyromatosis Am J Kidney Dis. 28 1996 502 507
63. L. Falvo, A. Catania, and S. Sorrenti Relapsing secondary hyperparathyroidism due to multiple nodular formations after total parathyroidectomy with autograft Am Surg 69 2003 998 1002